Beranda › Karsinoma Sel Skuamosa Kepala dan Leher › Virginia › Arlington
Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di Arlington, VA
26 studi untuk Karsinoma Sel Skuamosa Kepala dan Leher mencari peserta di lokasi sekitar Arlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Menerima pesertaFase 1
- Site 04, Fairfax · 11 mi jauhnya
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Menerima pesertaFase 1
- ALX Center 2, Fairfax · 11 mi jauhnya
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Menerima pesertaFase 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
- Inova Fairfax Hospital, Falls Church · 4 mi jauhnya
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauhnya
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Menerima pesertaFase 1/2
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Menerima pesertaFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Research Site, Fairfax · 11 mi jauhnya
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Menerima pesertaFase 1
- Normunity Investigational Site, Fairfax · 11 mi jauhnya
A Study of DM005 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi jauhnya
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- NEXT, Fairfax · 11 mi jauhnya
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Menerima pesertaFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi jauhnya
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Menerima pesertaFase 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mi jauhnya
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Menerima pesertaFase 1
- Dren Investigational Site, Fairfax · 11 mi jauhnya
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Menerima pesertaFase 1
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Research Site 102, Fairfax · 11 mi jauhnya
- Research Site 112, Fairfax · 11 mi jauhnya
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di kota lain
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- New York City, NY39 studi
- Nashville, TN39 studi
- St. Louis, MO28 studi
- Philadelphia, PA26 studi
- Chicago, IL26 studi
- Atlanta, GA24 studi
- San Antonio, TX22 studi
- New Haven, CT22 studi
- Pittsburgh, PA22 studi
Studi lain di Arlington
- Kanker Paru Non-Sel Kecil104 studi
- Kanker Metastatik53 studi
- Kanker Kolorektal52 studi
- Kanker (semua jenis)48 studi
- Kanker Payudara47 studi
- Kanker Ovarium46 studi
- Kanker Paru41 studi
- Kanker Endometrium39 studi
- Kanker Pankreas33 studi
- Kanker Paru Sel Kecil23 studi
- Kanker Lambung20 studi
- Kanker Payudara Triple-Negatif20 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.